These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6624666)

  • 1. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
    Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
    Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide: long-term treatment using a reduced dosing schedule.
    Flowers D; O'Gallagher D; Torres V; Miura D; Somberg JC
    Am J Cardiol; 1985 Jan; 55(1):79-83. PubMed ID: 3966401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of resistant ventricular tachycardia with flecainide acetate. Flecainide Ventricular Tachycardia Study Group.
    Am J Cardiol; 1986 Jun; 57(15):1299-304. PubMed ID: 3717029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study.
    Buxton AE; Marchlinski FE; Flores BT; Miller JM; Doherty JU; Josephson ME
    Circulation; 1987 Jun; 75(6):1178-85. PubMed ID: 3568327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
    Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
    Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
    Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
    Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G; Borggrefe M; Yeh HL; Seipel L
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with electrophysiologically guided therapy of ventricular tachycardia with flecainide: summary of long-term follow-up.
    Anderson JL
    Am J Cardiol; 1984 Feb; 53(5):79B-86B. PubMed ID: 6695820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia].
    Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
    Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
    Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophysiological anti-arrhythmia effects of tiracizine in ventricular tachycardia].
    Volkmann H; Kühnert H; Dannberg G; Heinke M; Leeder U; Popp U
    Z Gesamte Inn Med; 1991 Dec; 46(17):635-41. PubMed ID: 1776306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.
    Capparelli EV; Kluger J; Regnier JC; Chow MS
    J Clin Pharmacol; 1988 Mar; 28(3):268-75. PubMed ID: 3129456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.